Pharming Group N.V.
PHGUF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$709.82M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $709.82 Million |
|---|---|
| Enterprise Value | $664.83 Million |
| Earnings per Share | $0 |
| Beta | 0.09 |
| Outstanding Shares | 707,781,240 |
Return
| Return on Equity | 3.13% |
|---|---|
| Return on Assets | 1.81% |
| Return on Invested Capital | 1662.21% |
Valuation & Multiples
| P/E Ratio | 66.79 |
|---|---|
| PEG | -103.02 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | 0.11 |
| Enterprise Value to Net Income | 78 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 27, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$117.60 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$103.54 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Pharming Group N.V.
407 employees
CEO: Sijmen de Vries
Based in Leiden, the Netherlands, Pharming Group N.V. operates as a biopharmaceutical firm dedicated to advancing and marketing protein replacement therapies and precise medical solutions. Its global efforts, spanning the United States, ...